Aims and Objectives: Compare the level antioxidant in HIV positive pregnant, normal pregnant and non pregnant women, socioeconomic status and to determine oxidative stress levels in all study groups

1. Glutathione (GSH) concentration
2. Malondialdehyde (MDA) concentration
3. Total Antioxidant Status (TAS)
4. Glutathione Peroxidase (GPx)
5. Super Oxide Dismutase (SOD)

Result and Conclusion: The activity of GR, GPx, SOD, MDA and total antioxidant in non pregnant, normal pregnant and HIV positive pregnant women. The activity in non pregnant women and normal pregnant women were 9.27 ±1.74, 47.30 ± 10.27,  1329.7  ± 111.8, 3.03  ± 0.49, 1.47 ±  0.18 and 4.37 ± 0.79, 27.17 ± 2.76, 944.9  ± 193.1, 4.50 ± 0.32, 1.19 ± 0.20 respectively. And the activity was 3.51 ± 1.15, 19.54 ± 2.51, 675.3 ± 125.9, 5.46 ± 0.55, and 0.88 ± 0.15 found in HIV pregnant women. It shows that the level of antioxidant in HIV pregnant women was significantly decreased but MDA level was slightly increased found compare to non pregnant and normal pregnant women.

On the basis of our result we concluded that the HIV positive pregnant women experience more free radical injury than those with HIV negative pregnant women. Due to oxidative stress, when highly induce it is involved in tissue damage. These mechanisms lead to the decrease of the antioxidant capacity of the body in HIV positive pregnant women.

Keywords: GR, GPx, SOD, MDA, HIV, AIDS, CD4, ROS, GSH and SES.

1. Hymes KB, Cheung T, Greene JB, et al. Kaposi’s Sarcoma in homosexual men –a report of eight cases. Lancet 1981; 2(8247):598-600.
2. Piot P, Bartos M, Ghys PD, Walker N, Schwartlander B. The global impact of HIV/AIDS. Nature (London) 2001; 410:968-73.
3. UNAIDS (2016) 'Prevention Gap Report'.
4. NACO (2015) ‘Annual report 2015 -16’.
5. NACO (2015) ‘Annual report 2015 -16’.
6. Israel N, Gougerot-Pocidalo MA Oxidative stress in human immunodeficiency virus infection. Cell Mol Life Sci 1997; 53(11-12): 864- 870.
7. Repetto M, Reides C, Gomez Carretero ML, Costa M, et al. Oxidative stress in blood of HIV infected patients. Clin. Chim. Acta 1996; 255(2): 107-117.
8. Perl A, Banki K. Genetic and Metabolic Control of the Mitochondrial Transmembrane Potential and Reactive Oxygen Intermediate Production in HIV Disease. Antioxid Redox Signal 2000; 2(3): 551-573.
9. Greenspan HC, Aruoma OI, Arouma O. Could oxidative stress initiate programmed cell death in HIV infection? A role for plant derived metabolites having synergistic antioxidant activity. Chem Biol Interact 1994; 91(2-3): 187-197.
10. Walmsley SL, Winn LM, Harrison ML, Uetrecht JP, Wells PG. Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications. AIDS 1997; 11(14): 1689-1697.
11. Papadopulos-Eleopulos E. Reappraisal of AIDS –is the oxidation induced by the risk factors the primary cause? Med Hypotheses 1988; 25(3): 151-62.
12. Bitterlich G, Larcher C, Solder B, et al. Effect of D-penicillamine on the expression and propagation of the human immunodeficiency virus by H9 T-lymphoblastoid cells. Arzneimittelforschung1989; 39(8):825-8.
13. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, Fauci AS. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc Nat Acad Sci USA 1991; 88(3):986-90.
14. Quanungo S, Mukherjea M. Ontogenic profile of some antioxidants and lipid per-oxidation in human placental and fetal tissues. Mol Cell Biochem. 2000;1–2:11–19.
15. Granot E, Kohen R. Oxidative stress in childhood—in health and disease states. Clin Nutr. 2004; 23:3–11.
16. Sies H. Oxidative stress: oxidants and antioxidants. Am J Med. 1991; 91:3C.
17. Basu I, Jana S, Rotheram, Borus MJ, Swendeman ,D, Lee SJ, Newman P, Weiss R. HIV Prevention Among Sex Workers in India. J Acquir Immune Defic Syndr. 2004 Jul; 36(3): 845–852.
18. Magadi MA: Understanding the gender disparity in HIV infection across countries in sub-Saharan Africa: evidence from the Demographic and Health Surveys. Soc Heal Illn 2011; 33(4):522–539.
19. Gillespie S, Kadiyala S, Greener R. Is poverty or wealth driving HIV transmission? AIDS 2007; 21(7):S5–S16.
20. Negi, K. S., et al. "Knowledge, Attitude and Perception about HIV/AIDS among Pregnant Women in Rural Area of Dehradun." JK Sci 2006;8(3):133-8.
21. Fortson JG: The gradient in sub-Saharan Africa: socioeconomic status and HIV/AIDS. Demography 2008;45(2):303–22.
22. Goldberg D.M. & Spooner RJ (1983) in Methods of Enzymatic Analysis (Bergmeyen, H.V. Ed.) 3rd edn. Vol 3, pp 258-265.
23. Paglia, D.E. and Valentine, W.N., J. Lab. Clin. Med.1967; 70: 158.
24. Miller, N.J., Rice-Evans, C., Davies, M.J., Gopinathan, V. and Milner, A., Clinical Science (1993) 84, 407-412.
25. Woolliams JA, Wiener G, Anderson PH, McMurray CH Research in Veterinary Science 1983, 34: 253-256.
26. Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G. Gluthione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci 2005;9:361‑
27. Pasupathi P, Ramachandran T, Sindhu PJ, Saravanan G, Bakthavathsalam G (2009) Enhanced Oxidative Stress Markers and Antioxidant Imbalance in HIV Infection and AIDS Patients. J Sci Res 1(2): 370-380.
28. Awodele O, Olayemi SO, Nwite JA, Adeyemo TA (2012) Investigation of the levels of oxidative stress parameters in HIV and HIV-TB co-infected patients. J Infect Dev Ctries 6(1): 79-85.
29. Wickens D. Oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 1981; 18: 158-62.
30. Kodliwadmath SM, Sadashivadu B. and Kodliwadmath MV. Serum Malondiald-ehyde and ceruloplasmin Levels in toxaemia of pregnancy. J of Obstetrics and Gynecology of India 1989; 5: 648-51.
31. Carone D, Loverro, Gereco P, Capuano F. Lipid peroxidation products and antioxidant enzymes in red blood cells during normal and diabetic pregnancy. Eur J Obstet Gyneccol Repro Biol 1993; 51: 103-9.
32. Stephen, Wisdom, Wilson R, Mc Killop H. Antioxidant systems in normal pregnancy and in pregnancy induced hypertension. Am J Obstet Gyncecol 1991; 165: 1701-4.
33. Davidge ST, Hubel CA, Brayden RN, Capeless EC, Mc Laughlin MK. Sera antioxidant activity in uncomplicated and pre-eclamptic pregnancies. Obstetrics and Gynecology 1992; 79(6): 897-901.
34. Behne D, Wolters W. Selenium content and glutathione peroxidase activity in the plasma and erythrocytes of nonpregnant and pregnant women. J Clin chem Clin Biochem 1979; 17: 133-5.
35. Pathak SS, Shetty DN. Essentially Zinc in pregnancy to maintain antioxidant status. The Indian Practitioner 2001; 54(11): 766-70.
36. Yu BP. Cellular defenses against damage from reactive oxygen species. Phy Rev 1994; 74(1): 139-62.
37. Obermeyer CM, Bott S, Bayer R, Desclaux A, Baggaley R; MATCH Study Group (2013) HIV testing and care in Burkina Faso, Kenya, Malawi and Uganda: ethics on the ground. BMC International Health and Human Rights. 2013; 13, 6.
38. WHO, UNAIDS, UNICEF (2010) Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector. Progress Report, 2010. World Health Organization, Joint United Nations Programme on HIV/AIDS, UNICEF, Geneva.

Rajesh Bhanudas Rajekar

Assistant Professor Dept. of Biochemistry

Grant Government Medical College and JJ Group of Hospital Byculla Mumbai (MS)

Email Id:  This email address is being protected from spambots. You need JavaScript enabled to view it. Mob no. 07999678840.